United Therapeutics | UTHR - Stock


United Therapeutics reported $176.5M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Amarin USD 184.7M 13.46M Sep/2025
Ardelyx USD 129.36M 107.08M Sep/2025
Baxter International USD 2.46B 76M Sep/2025
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.21B 64.9M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Halozyme Therapeutics USD 185.8M 4.29M Sep/2025
Insmed USD 120.96M 13.36M Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
J&J USD 14.15B 734M Sep/2025
Moderna USD 332M 92M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025